McCourt Marion
EVP Commercial
McCourt Marion has filed 3 SEC Form 4 filings (5 transaction rows) across 1 company, with disclosures dating back to 2025. 3 of those filings fall inside the rolling window. Most recent filing: Sep 3, 2026.
On the most recent filing, McCourt Marion is listed as EVP Commercial at REGENERON PHARMACEUTICALS, INC. Inside the rolling window, McCourt Marion reported no open-market purchases and 2 open-market sales totaling $2.0M in REGN. The largest disclosed transaction in the window is a sale of 1,215 REGN shares on Sep 2, 2026, worth $1.0M.
Companies traded
Other insiders at REGN
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$2.0M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has McCourt Marion made?
McCourt Marion has filed 3 SEC Form 4 filings (5 transaction rows) across 1 company since 2025.
Which companies does McCourt Marion trade?
McCourt Marion has filed SEC Form 4 disclosures for 1 company, including REGN.
When was McCourt Marion's most recent SEC Form 4 filing?
McCourt Marion's most recent SEC Form 4 filing on Tracefour is dated Sep 3, 2026.
What is McCourt Marion's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, McCourt Marion is listed as EVP Commercial.
What is McCourt Marion's total buy and sell value in the current window?
Inside the rolling retention window, McCourt Marion bought $0 and sold $2.0M based on SEC Form 4 filings.
What was McCourt Marion's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 1,215 REGN shares on 2026-09-02, worth $1.0M, per SEC Form 4 filings.